Evaluation of Blood Pressure Changes Using Ambulatory Blood Pressure Monitoring (ABPM) in Children Undergoing Kidney Transplantation and its Relationship with Left Ventricular Mass Index, and Level of Serum Angiotensin and Atrial Natriuretic Peptide

Evaluation of Blood Pressure Changes Using Ambulatory Blood Pressure Monitoring (ABPM) in Children Undergoing Kidney Transplantation and its Relationship with Left Ventricular Mass Index, and Level of Serum Angiotensin and Atrial Natriuretic Peptide

Background: Hypertension is a problem in patients undergoing kidney transplantation. This problem can affect renal functioning, and increase heart failure and death in these patients. This study aimed to determine changes in blood pressure using ambulatory blood pressure monitoring (ABPM) in childre...

Full description

Bibliographic Details
Main Authors:	Alaleh Gheisari, Mohammad Reza Sabri, Hamid Reza Pirpiran, Shaghayegh Haghjooy Javanmard
Format:	Article
Language:	fas
Published:	Vesnu Publications 2012-03-01
Series:	مجله دانشکده پزشکی اصفهان
Subjects:	Angiotensin Left ventricular mass index Atrial natriuretic peptide Kidney transplantation Serum angiotensin level
Online Access:	http://jims.mui.ac.ir/index.php/jims/article/view/1050

Similar Items

Effect of Angiotensin Receptor Inhibitors on Endothelial Dysfunction
by: Alaleh Gheisari, et al.
Published: (2011-10-01)

Advances in angiotensin-(1-7) and atrial fibrillation
by: Yan-Guang Miao, et al.
Published: (2019-06-01)

The role and mechanisms of angiotensin II in regulating the natriuretic peptide gene expression in response to cardiac overload
by: Suo, M. (Maria)
Published: (2002)

Atrial natriuretic peptide in aging rats : evidence for altered processing, secretion and receptor binding
by: Kao, Jonathan
Published: (2010)

Astaxanthin lowers blood pressure and lessens the activity of the renin-angiotensin system in Zucker Fatty Rats
by: Harry G. Preuss, et al.
Published: (2009-01-01)

Inhibition of pulsatile luteinizing hormone release by atrial natriuretic peptide and brain natriuretic peptide in the ovariectomized rat
by: Zhang, Jin
Published: (2010)

Stroke, high blood pressure and the renin-angiotensin-aldosterone system – new developments
by: Jeffrey eAtkinson
Published: (2011-04-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Renin-angiotensin system antagonists, glomerular filtration rate and blood pressure
by: D.D. Ivanov
Published: (2018-02-01)

Paracrine and transcription factors mediating the natriuretic peptide gene expression during hemodynamic stress
by: Marttila, M. (Minna)
Published: (1999)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats
by: Shao-Jung Hsu, et al.
Published: (2020-04-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

The Role of Alpha Atrial Natriuretic Hormone in Pneumonectomy: An Experimental Study
by: Murat Akkuş, et al.
Published: (2019-07-01)

Cardiovascular effects of atrial natriuretic peptide (ANP).
Published: (1990)

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway
by: Wenkui Lv, et al.
Published: (2020-11-01)

Geniposidic acid upregulates atrial natriuretic peptide secretion and lowers blood pressure in spontaneously hypertensive rats
by: Kozo Nakamura, et al.
Published: (2018-01-01)

Chronic administration of pharmacological doses of angiotensin 1‐7 and iodoangiotensin 1‐7 has minimal effects on blood pressure, heart rate, and cognitive function of spontaneously hypertensive rats
by: Filipe F. Stoyell‐Conti, et al.
Published: (2021-04-01)

Cardiac markers in five different breeds of rabbits (Oryctolagus cuniculus Linnaeus, 1758) used for cardiovascular research
by: Felipp S. Ferreira, et al.

Comparative characteristic of the brain natriuretic peptide and angiotensin II expression index in the structure of locus coeruleus of brain stem in rats with arterial hypertension of various origins
by: M. V. Danukalo, et al.
Published: (2019-09-01)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

Effect of hypotensive hypovolemia and thoracic epidural anesthesia on plasma pro-atrial natriuretic peptide to indicate deviations in central blood volume in pigs: a blinded, randomized controlled trial
by: Strandby RB, et al.
Published: (2019-06-01)

From gene to protein - experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
by: Sheila K Patel, et al.
Published: (2014-06-01)

Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction
by: Akif Arslan, et al.
Published: (2016-01-01)

Context-dependent effects of the renin-angiotensin-aldosterone system on blood pressure in a group of African ancestry
by: Scott, Leon
Published: (2012)

Thrombin Induces Angiotensin II-Mediated Senescence in Atrial Endothelial Cells: Impact on Pro-Remodeling Patterns
by: Hira Hasan, et al.
Published: (2019-10-01)

Differential effect of angiotensin II and blood pressure on hippocampal inflammation in mice
by: M. Florencia Iulita, et al.
Published: (2018-02-01)

Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis
by: Jonathan A. Batty, et al.
Published: (2018-08-01)

Comparison of N-acetylcysteine and angiotensin converting enzyme inhibitors in blood pressure regulation in hypertensive patients
by: Arsalan Khaledifar, et al.
Published: (2015-01-01)

Cisplatin-induced nephrotoxicity alters blood pressure response to angiotensin II administration in rats
by: Aghdas Dehghani, et al.
Published: (2016-01-01)

Serum activity of Angiotensin converting enzyme and blood pressure response to acute dynamic exercise
by: Emina Nakać-Ićindić, et al.
Published: (2004-11-01)

The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19
by: Alessandro Bellis, et al.
Published: (2020-11-01)

Neuroendocrine control of body fluid homeostasis
by: McCann S.M., et al.
Published: (2003-01-01)

The effects of blocking angiotensin receptors on early stages of diabetic nephropathy
by: Alaleh Gheissari, et al.
Published: (2012-01-01)

Atrial natriuretic peptide and feeding activity patterns in rats
by: Oliveira M.H.A., et al.
Published: (1997-01-01)

Serum atrial natriuretic peptide: a suspected biomarker of breast cancer
by: Maha E. Houssen, et al.
Published: (2017-03-01)

Cadherin-11 Deficiency Attenuates Ang-II-Induced Atrial Fibrosis and Susceptibility to Atrial Fibrillation
by: Cao W, et al.
Published: (2021-07-01)

Renin-angiotensin system gene polymorphisms and high blood pressure in Lithuanian children and adolescents
by: Sandrita Simonyte, et al.
Published: (2017-09-01)

Atrial flutter/fibrillation in patients receiving transcatheter closure of atrial septal defect
by: Shuenn-Nan Chiu, et al.
Published: (2017-07-01)